Latest news with #Financials
Yahoo
19 hours ago
- Business
- Yahoo
Verizon Climbs 5% on Earnings Beat, Raised Profit Forecast
Verizon (VZ, Financials) gained nearly 5% Monday after reporting better-than-expected second-quarter earnings and raising the lower end of its full-year profit outlook. The telecommunications provider posted adjusted earnings per share of $1.22 on revenue of $34.5 billion, up 5.2% year over year and above Visible Alpha estimates. Verizon now expects adjusted EPS to grow between 1% and 3% in 2025, up from a previous forecast that started at flat. The company added 293,000 broadband internet subscribers in the quarter, exceeding projections of 224,100. Verizon also lost 51,000 wireless postpaid phone customers, an improvement over the prior year, and added 50,000 prepaid wireless subscribers versus a decline a year earlier. This article first appeared on GuruFocus.
Yahoo
19 hours ago
- Business
- Yahoo
Arm Rises 3% as Wells Fargo Lifts Price Target to $175
Arm (ARM, Financials) gained more than 3% Monday after Wells Fargo boosted its price target for the chip designer to $175 from $145, citing strong prospects tied to artificial intelligence. Shares ended the day near $162 and are up about 33% so far in 2025. The firm develops CPU architectures used by Nvidia (NVDA, Financials), Microsoft (MSFT, Financials) and Alphabet's Google (GOOGL, Financials). According to Wells Fargo's Sunday note to clients, growing demand for AI infrastructure especially from data centers could accelerate Arm's royalty revenue this fiscal year. Wells Fargo said it expects Arm's AI and custom silicon designs to drive meaningful royalty revenue growth, despite uncertainty over tariffs. Arm will report fiscal Q1 earnings after the U.S. market closes on July 30. This article first appeared on GuruFocus.
Yahoo
5 days ago
- Business
- Yahoo
Viatris Stock Slides After Phase 3 Blepharitis Drug Trial Misses Key Target
Viatris (VTRS, Financials) shares fell 3.6% on Friday after the firm said that its late-stage clinical study of the blepharitis medication MR-139 did not fulfill its main goal. The study examined pimecrolimus 0.3% ophthalmic ointment on 477 individuals for 12 weeks. Its goal was to get rid of eyelid debris, which is a major sign of blepharitis, but it didn't completely go away after six weeks of is currently thinking about its choices. The company's Chief R&D Officer said that the team might change its plans for future MR-139 trials. Viatris is still hopeful, even though this setback. Its pipeline still contains potential therapies like Tyrvaya and RYZUMVI, and it recently published good findings from two other Phase 3 studies, LYNX-2 and VEGA-3, which were looking at keratorefractive problems and presbyopia, company's long-term plan is still to work on treatments for anterior segment disorders in ophthalmology, and management have said they will keep working on these unmet requirements. This article first appeared on GuruFocus. Sign in to access your portfolio
Yahoo
6 days ago
- Business
- Yahoo
UBS Starts Motorola Solutions at Buy, Sees Nearly 20% Upside
Motorola Solutions (MSI, Financials) got a vote of confidence from UBS on Wednesday as analyst Andrew Spinola initiated coverage with a buy rating and a $490 price target implying roughly 19% upside from Tuesday's close. Warning! GuruFocus has detected 4 Warning Signs with JOBY. We think MSI is attractive at 27x NTM and we expect it to re-rate to 29x as growth accelerates into '26, Spinola wrote. UBS sees multiple catalysts for the reacceleration: a recovery in Motorola's core Land Mobile Radio business, which had recently slowed; growth in its Video segment; and an expanded total addressable market following the acquisition of Silvus Technologies, which enhances the company's public safety communications and mesh networking capabilities. Spinola said the market hasn't fully appreciated the scale of the company's transformation. The new, transformed Motorola is now a public safety/security solutions platform with a 5x larger TAM and better growth profile compared to 10 years ago, he wrote. Despite a more than 11% decline in the stock year to date, MSI's long-term growth trajectory could help close the gap with broader market performance, UBS suggested. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
UBS Starts Motorola Solutions at Buy, Sees Nearly 20% Upside
Motorola Solutions (MSI, Financials) got a vote of confidence from UBS on Wednesday as analyst Andrew Spinola initiated coverage with a buy rating and a $490 price target implying roughly 19% upside from Tuesday's close. Warning! GuruFocus has detected 4 Warning Signs with JOBY. We think MSI is attractive at 27x NTM and we expect it to re-rate to 29x as growth accelerates into '26, Spinola wrote. UBS sees multiple catalysts for the reacceleration: a recovery in Motorola's core Land Mobile Radio business, which had recently slowed; growth in its Video segment; and an expanded total addressable market following the acquisition of Silvus Technologies, which enhances the company's public safety communications and mesh networking capabilities. Spinola said the market hasn't fully appreciated the scale of the company's transformation. The new, transformed Motorola is now a public safety/security solutions platform with a 5x larger TAM and better growth profile compared to 10 years ago, he wrote. Despite a more than 11% decline in the stock year to date, MSI's long-term growth trajectory could help close the gap with broader market performance, UBS suggested. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
